brokerage reports
Jump to
96 Results Found
  • Buy Divi’s Lab; target of Rs 4530: Motilal Oswal Mar 25, 2021 02:33 PM IST

    Buy Divi’s Lab; target of Rs 4530: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Lab recommended buy rating on the stock with a target price of Rs 4530 in its research report dated March 24, 2021.

  • Buy Divis Laboratories: target of Rs 4500: Sharekhan Mar 24, 2021 03:40 PM IST

    Buy Divis Laboratories: target of Rs 4500: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4500 in its research report dated March 23, 2021.

  • Gladiator Stocks - Divis Laboratories: ICICI Direct Mar 22, 2021 03:05 PM IST

    Gladiator Stocks - Divis Laboratories: ICICI Direct

    According to ICICI Direct, Buy Divis Laboratories in the range of Rs 3280.00–3325.00 for target price of Rs 3740.00 with a stop loss of Rs 3110.00. Time Frame: Six months.

  • Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct Feb 10, 2021 03:30 PM IST

    Buy Divi’s Laboratories; target of Rs 4440: ICICI Direct

    ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 4440 in its research report dated February 06, 2021.

  • Divi’s Labs: All set to reap investments Feb 08, 2021 09:54 AM IST

    Divi’s Labs: All set to reap investments

    Since the macro context is fragile, eventually liquidity will continue to chase cash rich and cash flow positive businesses such as Divi’s Labs

  • PI Industries: Custom synthesis giant waiting for another orbit Feb 05, 2021 12:25 PM IST

    PI Industries: Custom synthesis giant waiting for another orbit

    We like the PI Industries' focus on custom synthesis and manufacturing which has helped it become a “partner of choice” for global agrochemical majors

  • Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate Jan 25, 2021 09:35 AM IST

    Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

    We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers

  • Buy Divi's Laboratories; target of Rs 4425: ICICI Direct Dec 30, 2020 12:42 PM IST

    Buy Divi's Laboratories; target of Rs 4425: ICICI Direct

    ICICI Securities is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4425 in its research report dated December 30, 2020.

  • Buy Divis Laboratories: target of Rs 4175: Sharekhan Dec 07, 2020 02:02 PM IST

    Buy Divis Laboratories: target of Rs 4175: Sharekhan

    Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04, 2020.

  • Buy Divis Laboratories: target of Rs 3800: Sharekhan Nov 11, 2020 11:30 AM IST

    Buy Divis Laboratories: target of Rs 3800: Sharekhan

    Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06, 2020.

  • Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal Nov 10, 2020 12:12 PM IST

    Buy Divi’s Laboratories; target of Rs 3900: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated November 08, 2020.

  • Divi’s Labs: Improved growth visibility for custom synthesis, but valuation rich Nov 10, 2020 09:42 AM IST

    Divi’s Labs: Improved growth visibility for custom synthesis, but valuation rich

    Divi's Labs result re-emphasise the fact that the global trend of de-risking supply chains away from China is adding to order enquires and product dispatches

  • Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market Nov 09, 2020 01:38 PM IST

    Accumulate Divi's Laboratories; target of Rs 3515: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08, 2020.

  • Buy Divi's Laboratories; target of Rs 4205: ICICI Direct Nov 09, 2020 11:52 AM IST

    Buy Divi's Laboratories; target of Rs 4205: ICICI Direct

    ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated November 08, 2020.

  • Buy Divi’s Laboratories; target of Rs 3350: Motilal Oswal Aug 11, 2020 06:59 PM IST

    Buy Divi’s Laboratories; target of Rs 3350: Motilal Oswal

    Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3350 in its research report dated August 09, 2020.

  • Buy Divis Laboratories; target of Rs 3400: Sharekhan Aug 11, 2020 06:58 PM IST

    Buy Divis Laboratories; target of Rs 3400: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated August 07, 2020.

  • Buy Divi's Laboratories; target of Rs 3260: ICICI Direct Aug 10, 2020 01:01 PM IST

    Buy Divi's Laboratories; target of Rs 3260: ICICI Direct

    ICICI Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 3260 in its research report dated August 09, 2020.

  • Divi’s labs: Expensive for a reason Aug 10, 2020 08:09 AM IST

    Divi’s labs: Expensive for a reason

    Divi’s ongoing capex plan should be helpful in capitalising on the opportunity stemmiing from drug shortages, the pandemic and the shift away from China

  • Buy Divis Laboratories target of Rs 2700: Sharekhan Jun 10, 2020 06:20 PM IST

    Buy Divis Laboratories target of Rs 2700: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated June 08, 2020.

  • Hold Divi's Laboratories; target of Rs 2355: ICICI Direct Jun 10, 2020 08:23 AM IST

    Hold Divi's Laboratories; target of Rs 2355: ICICI Direct

    ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 2355 in its research report dated June 09, 2020.

  • Buy Divis Laboratories target of Rs 2430: Sharekhan Feb 24, 2020 10:40 AM IST

    Buy Divis Laboratories target of Rs 2430: Sharekhan

    Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2430 in its research report dated February 20, 2020.

  • Buy Divi’s Laboratories target of Rs 2200: Sharekhan Feb 10, 2020 03:48 PM IST

    Buy Divi’s Laboratories target of Rs 2200: Sharekhan

    Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated February 06, 2020.

  • Hold Divi's Laboratories; target of Rs 1850: ICICI Direct Nov 07, 2019 03:03 PM IST

    Hold Divi's Laboratories; target of Rs 1850: ICICI Direct

    ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1850 in its research report dated November 06, 2019.

  • Buy Divi’s Laboratories; target of Rs 1800: Sharekhan Aug 19, 2019 03:50 PM IST

    Buy Divi’s Laboratories; target of Rs 1800: Sharekhan

    Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated August 14, 2019.

  • Hold Divi's Laboratories; target of Rs 1640: ICICI Direct Aug 13, 2019 01:07 PM IST

    Hold Divi's Laboratories; target of Rs 1640: ICICI Direct

    ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1640 in its research report dated August 12, 2019.

Sections